USPH — US Physical Therapy Income Statement
0.000.00%
- $1.12bn
- $1.54bn
- $780.99m
Annual income statement for US Physical Therapy, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | C2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 495 | 553 | 605 | 671 | 781 |
| Cost of Revenue | |||||
| Gross Profit | 117 | 112 | 122 | 128 | 150 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 422 | 496 | 552 | 608 | 694 |
| Operating Profit | 72.6 | 56.8 | 52.5 | 63 | 86.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 73.2 | 55.6 | 49.4 | 60.2 | 77.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 57.9 | 43.4 | 37.2 | 45.6 | 58 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 40.8 | 32.2 | 28.2 | 31.4 | 39.6 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 31.1 | 29.3 | 18.1 | 27.7 | 21.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.3 | 2.8 | 2.18 | 2.22 | 1.57 |
| Dividends per Share |